Randomized trial of radiation therapy (RT) plus dibromodulcitol (DBD) versus RT plus BCNU in high grade astrocytoma

Journal of Neuro-Oncology

Volumn 33, Issue 3, 1997, Pages 239-250

  Elliott, Thomas E ^a   Dinapoli, Robert P ^b   O'Fallon, Judith R ^b   Krook, James E ^a   Earle, John D ^b   Morton, Roscoe F ^c   Levitt, Ralph ^d   Tschetter, Loren K ^e   Scheithauer, Bernd W ^b   Pfeifle, Delano M ^f   Twito, Donald I ^g   Nelimark, Robert A ^e  

^a Duluth Community Clinical Oncology Program   (United States)

^b MAYO CLINIC   (United States)

^c Iowa Oncology Research Association CCOP   (United States)

^d MeritCare Hospital   (United States)

^e Sioux Community Cancer Consortium   (United States)

^f Quain and Ramstad Clinic   (United States)

^g BILLINGS CLINIC   (United States)

Author keywords

BCNU; Chemotherapy; Dibromodulcitol; High grade astrocytoma; Radiation therapy

Indexed keywords

CARMUSTINE; MITOLACTOL;

ADULT; ARTICLE; ASTROCYTOMA; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DERMATITIS; DRUG EFFICACY; FEMALE; HEMATOLOGIC DISEASE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NAUSEA; ORAL DRUG ADMINISTRATION; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE; SURVIVAL TIME; THROMBOCYTE COUNT; VOMITING;

ALGORITHMS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN NEOPLASMS; CARMUSTINE; COMBINED MODALITY THERAPY; FEMALE; GLIOBLASTOMA; HUMANS; MALE; MIDDLE AGED; MITOLACTOL; SURVIVAL RATE;

EID: 8244256665     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005735405986     Document Type: Article

References (27)

1. Walker MD, Gehan EA: Clinical studies in malignant gliomas and their treatment with nitrosoureas. Cancer Treat Rep 60: 713-716, 1976
2. Levin VA, Wilson CB: Chemotherapy: the agents in current use. Brain Tumors. Semin Oncol 2: 63-67, 1975
3. Walker MD, Alexander E, Hunt WE, MacCarty CS, Mahaley MS, Mealey J, Norrell HA, Owens G, Ransohoff J, Wilson CB, Gehan EA, Strike TA: Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas: a cooperative clinical trial. J Neurosurg 49: 333-343, 1978
4. Walker MD, Green SB, Byar DP, Alexander E, Batzdorf U, Brooks WH, Hunt WE, MacCarty CS, Mahaley MS, Mealey J, Owens G, Ransohoff J, Robertson JT, Shapiro WR, Smith KR, Wilson CB, Strike TA: Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N Engl J Med 303: 1323-1329, 1980
5. Nelson DF, Diener-West M, Horton J, Chang CH, Schoenfeld D, Nelson JS: Combined modality approach to treatment of malignant gliomas - Re-evaluation of RTOG 7401/ ECOG 1374 with long-term follow-up: a joint study of the Radiation Therapy Oncology Group and the Eastern Cooperative Oncology Group. NCI Monogr 6: 279-284, 1988
6. Institoris L, Horvath IP, Pethes G, Eckhardt S: Metabolic pathways of cytostatic dibromohexitals. Cancer Chemother Rep 51: 261-267, 1967
7. Geran RI, Congleton GF, Dudeck LE, Abbott BJ, Gargus JL: A mouse ependymoblastoma as an experimental model for screening potential antineoplastic drugs. Cancer Chemother Rep (Part 2) 4: 53-87, 1974
8. Kellner B, Nemeth L, Sugar J, Gati E, Palyi I, Dobrossy L: Pharmacology of 1,6 dibromo-1,6 dideoxydulcitol and its cytostatic effect on transplantable tumors. Arzneim Forsch 17: 1037-1043, 1967
9. Espana RT, Wiernik PA, Walker MD: Phase II study of dianhydrogalactitol in malignant glioma. Cancer Treat Rep 62: 1199-1200, 1978
10. Eagan RT, Childs DS, Layton DD, Laws ER, Bisel HF, Holbrook MA, Fleming TR: Dianhydrogalactitol and radiation therapy. Treatment of supratentorial glioma. JAMA 241: 2046-2050, 1979
11. Eckhardt S: Ten-year international clinical experience with DBD in the treatment of malignant diseases. In: Eckhardt S (ed) 'Dibromodulcitol'. Medicina, Budapest, 1982, pp 174-189
12. Mischler NE, Earhart RH, Carr B, Tormey DC: Dibromodulcitol. Cancer Treat Rev 6: 191-204, 1979
13. Kernohan JW, Mabon RF, Svien HJ, Adson AW: A simplified classification of gliomas. Proc Staff Meet Mayo Clin 24: 71-75, 1949
14. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 457-481, 1958
15. Mantel N: Evaluation of survival data and two new rank-order statistics arising in its consideration. Cancer Chemother Rep 50: 163-170, 1966
16. Cox DR: Regression models and life tables. J Royal Stat Soc (B) 74: 187-220, 1972
17. LeBlanc M, Crowley J: Relative risk trees for censored survival data. Biometrics 48: 411-425, 1992
18. Kleihues P, Burger PC, Scheithauer BW: Histological Typing of Tumors of The Central Nervous System. Springer-Verlag, 1993
19. Therneau TM, Grambsch P, Fleming TR: Martingale-based residuals for survival models. Biometricka 77: 147-160, 1990
20. Green SB, Byar DP, Walker MD, Pistenmaa DA, Alexander E, Batzdorf U, Brooks WH, Hunt WE, Mealey J, Odom GL, Paoletti P, Ransohoff J, Robertson JT, Selker RG, Shapiro WR, Smith KR, Wilson CB, Strike TA: Comparisons of carmustine, procarbazine, and high-dose methylprednisolone as additions to surgery and radiotherapy for the treatment of malignant glioma. Cancer Treat Rep 67: 121-132, 1983
21. Levin VA, Silver P, Hannigan J, Wara WM, Gutin PH, Davis RL, Wilson CB: Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarbazine, and vincristine (PCV) over BCNU for anaplastic gliomas NCOG CG61 final report. Int J Radiat Oncol Biol Phys 18: 321-324, 1990
22. Sellei C, Eckhardt S, Horvath IP, Kralovanszky J, Institoris L: Clinical and pharmacologic experience with dibromodulcitol (NSC-104800), a new anti-tumor agent. Cancer Chemother Rep 53: 377-384, 1969
23. Afra D: Treatment of gliomas by DBD. In: Eckhardt S (ed) D ibromodulcitol. Medicina Konyrkiado, Budapest, 1982, pp 189-199
24. Afra D, Kocsis B, Dobay J, Eckhardt S: Combined radiotherapy and chemotherapy with dibromodulcitol and CCNU in the postoperative treatment of malignant gliomas. J Neurosurg 59: 106-110, 1983
25. Levin VA, Edwards M, Gutin P, Vestnys P, Fulton D, Seager M, Wilson CB: Phase II evaluation of dibromodulcitol in the treatment of recurrent medulloblastoma, ependymoma, and malignant astrocytoma. J Neurosurg 61: 1063-1068, 1984
26. Afra D, Kocsis B, Kerpel-Fronius S, Eckhardt S: Dibromodulcitol-based combined postoperative chemotherapy of malignant astrocytomas and glioblastomas. J Neuro-Oncol 4: 65-70, 1986
27. Hildebrand J: Dibromodulcitol (DBD) and BCNU increase survival in adults with malignant gliomas (abstract). Neurol 44 (Suppl 2): A263-264, 1994